shutterstock-218141077
Gio.tto / Shutterstock.com
29 October 2014BiotechnologyAshley Roughton

HGS: where are we now with SPCs?

The dispute between Eli Lilly and Human Genome Sciences (HGS) over the patenting of the neutrokine-α protein and an antibody specific to it, belimumab, is continuing to the English Court of Appeal.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk